Meeting
2016 Genitourinary Cancers Symposium
Copy number alterations of P53, RB1, and MDM2 as prognostic markers in intermediate-risk prostate cancer.
Authors
Osman Mahamud
Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada
Osman Mahamud , Melvin Chua , Emilie Lalonde , Jonathan So , Alan Dal Pra , Alejandro Berlin , Michèle Orain , Valerie Picard , Helene Hovington , Alain Bergeron , Yves Fradet , Bernard Têtu , Gaetano Zafarana , Alice Meng , Julie Livingstone , Melania Pintilie , Michael Fraser , Theodorus van der Kwast , Paul Boutros , Robert G. Bristow
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 117)
DOI
10.1200/jco.2016.34.2_suppl.117
Abstract #
117
Poster Bd #
F11
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
Copy number alterations of DNA mismatch repair (MMR) genes as novel prognostic markers in localised prostate cancer (CaP).
First Author: Melvin Chua
Poster
2018 Genitourinary Cancers Symposium
A biopsy-based genomic classifier to predict biochemical failure after definitive radiation without hormone therapy in a prospective cohort of intermediate risk prostate cancer.
First Author: Melvin Chua
Poster
2016 Genitourinary Cancers Symposium
Prognostic value of copy-number alterations of the Cohesin complex in intermediate-risk prostate cancer recurrence.
First Author: Jonathan So
Poster
2024 ASCO Genitourinary Cancers Symposium
Chromatin modifications on plasma ctDNA as a tool to phenotype castration-resistant prostate cancer.
First Author: Asli Munzur